Back

Mobile health technology integrated care in atrial fibrillation patients according to polypharmacy: an analysis of the mAFA-II clinical trial

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation detection, prediction, and management Treatment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Bernadette Corica

University of Modena and Reggio Emilia, Modena (Italy)

6 More presentations in this session

Presentation thumbnail
Impact of atrial fibrillation on cardiac autonomic function in elderly patients
Doctor P. Haemmerle (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Circadian rhythm in atrial fibrillation detected by implantable loop recorder: a post-hoc analysis of a randomized clinical trial
Mr D. Spona (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
To monitor or not after detected AF, this is a question: report from the consumer-led screening programme of long-term extension mAFA cohort
Professor Y. Guo (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Quality of life after screening for atrial fibrillation: a substudy from a randomised screening trial
Doctor E. Kongebro (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Heart rate variability to predict 1-day atrial fibrillation episode onset using machine learning
Professor S. Carlier (Mons, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation detection, prediction, and management

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Impact of polypharmacy phenogroups on different heart failure phenotypes in patients with chronic heart failure (polypharmacy phenogroups and heart failure subgroups outcomes)
thumbnail
Congress Presentation
Multimorbidity increases risk of cardiovascular outcomes in permanent atrial fibrillation: data from the RACE II study
thumbnail
Congress Presentation
Risk of death, thromboembolic events, and bleeding in elderly patients with Atrial Fibrillation and Clinical Complexity who are not taking oral anticoagulation.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources